跳至主要内容
临床试验/CTIS2022-502512-36-00
CTIS2022-502512-36-00招募中1 期

Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung Disease - Xe-F-ILD-001

Aarhus University0 个研究点目标入组 30 人开始时间: 2022年11月11日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • Patients diagnosed with IPF or fibrotic ILD who fulfills PPF criteria, and are prescribed antifibrotic treatment., Age 18-90, Cognitively able to understand and participate in the study, Pre-menopausal women must be confirmed non-pregnant by an onsite test.

排除标准

  • Contraindications for MRI (Pacemaker, neurostimulator or cochlear implant; Metal foreign bodies such as fragments and irremovable piercings; Unsafe medical implants (safety of heart valves, hips and the like must be confirmed); Intrathoracic clips or coils; Cardiac pacemakers; Claustrophobia; Largest circumference including arms > 160 cm), Contraindications to gadolinium contrast (eGFR < 30 mL/min/1.73m2; Previous adverse reactions to gadolinium), Overlapping emphysematic disease where the emphysema-component outweighs the fibrosis, Unable to perform breath-hold of minimum 20 seconds., Allergy to Xenon, Breast feeding, Evidence of ongoing respiratory infections at time of MR examinations

研究者

相似试验

Hyperpolarized 129-Xenon MRI in Fibrosing... | 临床试验